Abstract
Inflammatory bowel disease (IBD) is a chronic relapsing inflammatory disease of the gastrointestinal tract of unclear etiology. Based on the clinical, radiologic, endoscopic and histological features, there are two major forms of IBD: Crohn's disease (CD) and ulcerative colitis (UC). The medical treatment of IBD patients has changed drastically in the last decade with the introduction of new targeted biologic therapies that complement the standard conventional therapy. Despite the positive response to biological therapy, there are still shortcomings in this type of treatment. Nutrition has a vital role in the management of inflammatory bowel disease. To improve nutrition problems and the quality of a patient's life, qualitative and quantitative dietary changes are needed. Clinical studies on probiotics in different clinical diseases have shown different results. Still, it is evident that probiotics have displayed efficacy in preventing and treating various medical conditions, particularly those involving the gastrointestinal tract.
Publisher
Centre for Evaluation in Education and Science (CEON/CEES)